European Society of Cardiology – 2023 (Amsterdam) LBCT Presentations Michelle O’Donoghue – RNA Inhibition of Lipoprotein(a) with Olpasiran: Effects on Oxidized Phospholipids and Primary Results of the OCEAN(a)-DOSE (TIMI 67) Off-Treatment Extension Period Other Presentations Rahul Aggarwal – Development and Validation of the DOAC Score – A Novel Bleeding Risk Prediction Tool for Patients with Atrial Fibrillation on Direct-Acting Oral Anticoagulants Marc Bonaca – Lipoprotein(a) and the risk of Major Adverse Limb Events in Patients with Stable Atherosclerotic Vascular Disease Marc Bonaca – Risk of Major Adverse Limb Events with Ezetimibe versus Placebo in Addition to Statin Therapy-Insights from the IMPROVE IT Trial Siddharth Patel – Efficacy and Safety of DOACs vs. Warfarin by Background Antiplatelet Therapy in 57,598 Patients With Atrial Fibrillation Siddharth Patel – Pre-shock and Normotensive Cardiogenic Shock in the Critical Care Cardiology Trials Network RegistryShare this:TwitterFacebookLike this:Like Loading...
